Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:AVAH NASDAQ:PGNY NASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$10.26+3.6%$9.32$8.07▼$15.48$1.42B0.93419,270 shs308,677 shsAVAHAveanna Healthcare$7.44+9.9%$6.71$3.73▼$10.32$1.47B1.931.31 million shs4.28 million shsPGNYProgyny$22.87-2.7%$18.27$16.10▼$28.75$1.84B0.911.66 million shs1.21 million shsTOIOncology Institute$4.04-1.0%$3.33$2.02▼$4.88$403.26M0.331.57 million shs2.40 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health+3.54%+3.94%+9.19%+7.06%-29.75%AVAHAveanna Healthcare+9.90%+7.20%+12.22%-6.18%+27.84%PGNYProgyny-2.72%+19.36%+33.20%+10.54%+4.62%TOIOncology Institute-1.46%-0.74%+19.53%+60.96%+70.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$10.26+3.6%$9.32$8.07▼$15.48$1.42B0.93419,270 shs308,677 shsAVAHAveanna Healthcare$7.44+9.9%$6.71$3.73▼$10.32$1.47B1.931.31 million shs4.28 million shsPGNYProgyny$22.87-2.7%$18.27$16.10▼$28.75$1.84B0.911.66 million shs1.21 million shsTOIOncology Institute$4.04-1.0%$3.33$2.02▼$4.88$403.26M0.331.57 million shs2.40 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health+3.54%+3.94%+9.19%+7.06%-29.75%AVAHAveanna Healthcare+9.90%+7.20%+12.22%-6.18%+27.84%PGNYProgyny-2.72%+19.36%+33.20%+10.54%+4.62%TOIOncology Institute-1.46%-0.74%+19.53%+60.96%+70.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.36Hold$14.2138.43% UpsideAVAHAveanna Healthcare 2.55Moderate Buy$10.2537.77% UpsidePGNYProgyny 2.85Moderate Buy$28.1823.23% UpsideTOIOncology Institute 2.60Moderate Buy$7.0073.27% UpsideCurrent Analyst Ratings BreakdownLatest TOI, PGNY, ARDT, and AVAH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026PGNYProgyny CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/11/2026PGNYProgyny Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$28.00 ➝ $30.005/11/2026PGNYProgyny Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$30.00 ➝ $31.005/7/2026ARDTArdent Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.00 ➝ $13.505/7/2026PGNYProgyny Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/20/2026TOIOncology Institute Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/13/2026AVAHAveanna Healthcare Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.004/6/2026AVAHAveanna Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C+)3/27/2026PGNYProgyny Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)3/25/2026ARDTArdent Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/25/2026AVAHAveanna Healthcare BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$11.00 ➝ $9.50(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$6.32B0.23$2.85 per share3.60$12.10 per share0.85AVAHAveanna Healthcare$2.43B0.67$0.76 per share9.82$0.93 per share8.00PGNYProgyny$1.29B1.39$0.72 per share31.93$5.61 per share4.08TOIOncology Institute$502.73M0.79N/AN/A($0.16) per share-25.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$135.81M$0.9510.808.482.202.09%13.85%4.48%N/AAVAHAveanna Healthcare$225.03M$1.027.2911.63N/A9.25%481.69%6.08%N/APGNYProgyny$58.52M$0.7729.7017.331.255.23%13.34%9.03%N/ATOIOncology Institute-$60.61M-$0.37N/AN/AN/A-7.42%N/A-24.68%N/ALatest TOI, PGNY, ARDT, and AVAH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026AVAHAveanna Healthcare$0.13$0.18+$0.05$0.19$613.22 million$647.92 million5/7/2026Q1 2026PGNYProgyny$0.2560$0.29+$0.0340$0.29$326.47 million$328.50 million5/7/2026Q1 2026TOIOncology Institute-$0.07-$0.02+$0.05-$0.02$142.10 million$147.44 million5/5/2026Q1 2026ARDTArdent Health$0.18$0.28+$0.10$0.28$1.58 billion$1.60 billion3/12/2026Q4 2025TOIOncology Institute-$0.08-$0.06+$0.02-$0.06$139.78 million$141.96 million3/4/2026Q4 2025ARDTArdent Health$0.35$0.32-$0.03$0.32$1.63 billion$1.61 billion2/26/2026Q4 2025PGNYProgyny$0.38$0.48+$0.10$0.14$314.26 million$318.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/AAVAHAveanna HealthcareN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.622.122.00AVAHAveanna Healthcare6.621.321.32PGNYProgynyN/A2.132.73TOIOncology InstituteN/A1.471.35Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/AAVAHAveanna Healthcare87.96%PGNYProgyny94.93%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.90%AVAHAveanna Healthcare5.30%PGNYProgyny9.90%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health25,200143.35 million140.63 millionOptionableAVAHAveanna Healthcare35,500217.51 million205.98 millionOptionablePGNYProgyny31078.33 million70.58 millionOptionableTOIOncology Institute66098.84 million90.44 millionNot OptionableTOI, PGNY, ARDT, and AVAH HeadlinesRecent News About These CompaniesThe Oncology Institute to Participate in B. Riley Securities Institutional Investor ConferenceMay 13 at 9:00 AM | globenewswire.comThe Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00May 11, 2026 | finance.yahoo.comOncology Institute Q1 Earnings Call HighlightsMay 9, 2026 | marketbeat.comThe Oncology Institute, Inc. (TOI) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comOncology Institute (NASDAQ:TOI) Issues Quarterly Earnings ResultsMay 8, 2026 | marketbeat.comThe Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue EstimatesMay 7, 2026 | zacks.comThe Oncology Institute Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.comWhat To Expect From The Oncology Institute Inc (TOI) Q1 2026 EarningsMay 6, 2026 | finance.yahoo.comConstellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2026May 5, 2026 | globenewswire.comOncology Institute (TOI) to Release Earnings on ThursdayApril 30, 2026 | marketbeat.comThe Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference CallApril 27, 2026 | globenewswire.comHere’s What Powered The Oncology Institute’s (TOI) GainsApril 20, 2026 | insidermonkey.comOncology Institute (NASDAQ:TOI) Director Mohit Kaushal Sells 38,433 SharesApril 17, 2026 | insidertrades.comMohit Kaushal Sells 38,433 Shares of Oncology Institute (NASDAQ:TOI) StockApril 16, 2026 | marketbeat.comOncology Institute (NASDAQ:TOI) Director Sells $200,501.00 in StockApril 16, 2026 | marketbeat.comThe Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period ImprovementApril 14, 2026 | markets.businessinsider.comInsider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Purchases 20,000 Shares of StockApril 14, 2026 | insidertrades.comThe Oncology Institute to Participate in the 25th Annual Needham Healthcare ConferenceApril 9, 2026 | markets.businessinsider.comOne Oncology Institute Insider Raised Their Stake In The Previous YearMarch 31, 2026 | finance.yahoo.comInsider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Purchases 125,000 Shares of StockMarch 26, 2026 | insidertrades.comOncology Institute (NASDAQ:TOI) Major Shareholder Jorey Chernett Acquires 25,000 SharesMarch 24, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 20265 Stocks Positioned to Win the AI Data Center BuildoutBy Bridget Bennett | April 20, 2026NVIDIA's Quantum Computing Play Just Sent IonQ and Rigetti Flying By Jeffrey Neal Johnson | April 15, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Anheuser-Busch Stock Jumps as Volume Growth Signals TurnaroundBy Chris Markoch | May 7, 2026TOI, PGNY, ARDT, and AVAH Company DescriptionsArdent Health NYSE:ARDT$10.26 +0.35 (+3.57%) Closing price 05/14/2026 03:59 PM EasternExtended Trading$10.32 +0.06 (+0.55%) As of 04:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Aveanna Healthcare NASDAQ:AVAH$7.44 +0.67 (+9.90%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$7.58 +0.14 (+1.94%) As of 06:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Progyny NASDAQ:PGNY$22.87 -0.64 (-2.72%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$22.66 -0.21 (-0.91%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Oncology Institute NASDAQ:TOI$4.04 -0.04 (-0.98%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$4.08 +0.04 (+0.87%) As of 05/14/2026 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
